Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(33)
•••
Post by Biofinderon May 25, 2018 3:25pm
229 Views
Post# 28082294

**The Biology of Healing and Hope (best slideshow to date)**

**The Biology of Healing and Hope (best slideshow to date)**This is by far their best slideshow presentation, full of information.
 
Page 5 gives PL’s commercialization timelines (for what it’s worth):
Page 32 has some gruesome photos:
Page 55 Small-Molecule Therapeutics Pipeline: News flow For Next 12 Months
Page 56 Plasma-Derived Therapeutics Pipeline: News flow For Next 12 Months
Page 57 Management Team (please keep your applause to a minimum  LOL!)
 
https://www.prometic.com/wp-content/uploads/2018/05/Prometic-Investor-Deck-March-6-2018-AIMCo.pdf

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities